BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 32777353)

  • 21. Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells.
    Mansour M; Palese P; Zamarin D
    J Virol; 2011 Jun; 85(12):6015-23. PubMed ID: 21471241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Apoptosis Induction by Newcastle Disease Virus LaSota Strain in Human Breast Carcinoma Cells.
    Kalantari A; Farashi Bonab S; Keyvanfar H; Mortazavi P
    Arch Razi Inst; 2020 Oct; 75(3):367-376. PubMed ID: 33025777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regression of solid breast tumours in mice by Newcastle disease virus is associated with production of apoptosis related-cytokines.
    Raihan J; Ahmad U; Yong YK; Eshak Z; Othman F; Ideris A
    BMC Cancer; 2019 Apr; 19(1):315. PubMed ID: 30947706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent Newcastle disease virus infection in bladder cancer cells is associated with putative pro-survival and anti-viral transcriptomic changes.
    Chan LC; Kalyanasundram J; Leong SW; Masarudin MJ; Veerakumarasivam A; Yusoff K; Chan SC; Chia SL
    BMC Cancer; 2021 May; 21(1):625. PubMed ID: 34044804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newcastle disease virus mediated apoptosis and migration inhibition of human oral cancer cells: A probable role of β-catenin and matrix metalloproteinase-7.
    Morla S; Kumar A; Kumar S
    Sci Rep; 2019 Jul; 9(1):10882. PubMed ID: 31350432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterization of an apoptotic strain of Newcastle disease virus isolated from an outbreak in India.
    Kumar U; Kumar S
    Cancer Gene Ther; 2015 Aug; 22(8):402-9. PubMed ID: 26251032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncolytic Newcastle disease virus induced degradation of YAP through E3 ubiquitin ligase PRKN to exacerbate ferroptosis in tumor cells.
    Sun Y; Tang L; Kan X; Tan L; Song C; Qiu X; Liao Y; Nair V; Ding C; Liu X; Sun Y
    J Virol; 2024 Mar; 98(3):e0189723. PubMed ID: 38411946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation.
    Fournier P; Bian H; Szeberényi J; Schirrmacher V
    Methods Mol Biol; 2012; 797():177-204. PubMed ID: 21948477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells.
    Ye T; Jiang K; Wei L; Barr MP; Xu Q; Zhang G; Ding C; Meng S; Piao H
    Am J Cancer Res; 2018; 8(8):1514-1527. PubMed ID: 30210920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagy is involved in recombinant Newcastle disease virus (rL-RVG)-induced cell death of stomach adenocarcinoma cells in vitro.
    Bu XF; Wang MB; Zhang ZJ; Zhao YH; Li M; Yan YL
    Int J Oncol; 2015 Aug; 47(2):679-89. PubMed ID: 26058483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.
    Kazimirsky G; Jiang W; Slavin S; Ziv-Av A; Brodie C
    Stem Cell Res Ther; 2016 Oct; 7(1):149. PubMed ID: 27724977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Ultra-Microscopic Changes and Proliferation of Apoptotic Glioblastoma Multiforme Cells Induced by Velogenic Strain of Newcastle Disease Virus AF2240.
    Ali- Saeed R; Alabsi AM; Ideris A; Omar AR; Yusoff K; Ali AM
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):757-765. PubMed ID: 30909682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the oncolytic potential of R
    Sharma KK; Kalyani IH; Mohapatra J; Patel SD; Patel DR; Vihol PD; Chatterjee A; Patel DR; Vyas B
    Arch Virol; 2017 Sep; 162(9):2705-2713. PubMed ID: 28578522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein Livin.
    Lazar I; Yaacov B; Shiloach T; Eliahoo E; Kadouri L; Lotem M; Perlman R; Zakay-Rones Z; Panet A; Ben-Yehuda D
    J Virol; 2010 Jan; 84(1):639-46. PubMed ID: 19864394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mechanisms of in vitro anti-tumor effects of a Newcastle disease virus].
    Meng S; Bai H; Hu M; Liu W; Wang L; Wu Y; Jiao X; Fan J
    Wei Sheng Wu Xue Bao; 2009 Apr; 49(4):512-7. PubMed ID: 19621640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptin enhances the oncolytic properties of Newcastle disease virus.
    Wu Y; Zhang X; Wang X; Wang L; Hu S; Liu X; Meng S
    Intervirology; 2012; 55(4):276-86. PubMed ID: 21865658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells.
    Shao X; Wang X; Guo X; Jiang K; Ye T; Chen J; Fang J; Gu L; Wang S; Zhang G; Meng S; Xu Q
    Front Oncol; 2019; 9():436. PubMed ID: 31192135
    [No Abstract]   [Full Text] [Related]  

  • 38. Analysis of PPI networks of transcriptomic expression identifies hub genes associated with Newcastle disease virus persistent infection in bladder cancer.
    Ahmad U; Abdullah S; Chau M; Chia SL; Yusoff K; Chan SC; Ong TA; Razack AH; Veerakumarasivam A
    Sci Rep; 2023 May; 13(1):7323. PubMed ID: 37147328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intratumoral Virotherapy with Wild-Type Newcastle Disease Virus in Carcinoma Krebs-2 Cancer Model.
    Yurchenko KS; Glushchenko AV; Gulyaeva MA; Bi Y; Chen J; Shi W; Adamenko LS; Shestopalov AM
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33806229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptotic induction of lung adenocarcinoma A549 cells infected by recombinant RVG Newcastle disease virus (rL-RVG) in vitro.
    Yan Y; Liang B; Zhang J; Liu Y; Bu X
    Mol Med Rep; 2015 Jan; 11(1):317-26. PubMed ID: 25322856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.